Initial experience with AI Pathway Companion: Evaluation of dashboard-enhanced clinical decision making in prostate cancer screening.

Autor: Henkel M; Research & Analytic Services University Hospital Basel, Basel, Switzerland.; Institute of Radiology, University Hospital Basel, Basel, Switzerland.; University Basel, Basel, Switzerland., Horn T; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Leboutte F; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Trotsenko P; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Dugas SG; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Sutter SU; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Ficht G; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Engesser C; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Matthias M; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Stalder A; Siemens Healthineers GmbH, Erlangen, Germany., Ebbing J; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Cornford P; Department of Urology, Liverpool University Hospitals NHS Trust, Liverpool, United Kingdom., Seifert H; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland., Stieltjes B; Research & Analytic Services University Hospital Basel, Basel, Switzerland.; Institute of Radiology, University Hospital Basel, Basel, Switzerland.; University Basel, Basel, Switzerland., Wetterauer C; University Basel, Basel, Switzerland.; Institute of Urology, University Hospital Basel, Basel, Switzerland.; Danube Private University, Krems, Austria.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2022 Jul 20; Vol. 17 (7), pp. e0271183. Date of Electronic Publication: 2022 Jul 20 (Print Publication: 2022).
DOI: 10.1371/journal.pone.0271183
Abstrakt: Purpose: Rising complexity of patients and the consideration of heterogeneous information from various IT systems challenge the decision-making process of urological oncologists. Siemens AI Pathway Companion is a decision support tool that provides physicians with comprehensive patient information from various systems. In the present study, we examined the impact of providing organized patient information in comprehensive dashboards on information quality, effectiveness, and satisfaction of physicians in the clinical decision-making process.
Methods: Ten urologists in our department performed the entire diagnostic workup to treatment decision for 10 patients in the prostate cancer screening setting. Expenditure of time, information quality, and user satisfaction during the decision-making process with AI Pathway Companion were recorded and compared to the current workflow.
Results: A significant reduction in the physician's expenditure of time for the decision-making process by -59.9% (p < 0,001) was found using the software. System usage showed a high positive effect on evaluated information quality parameters completeness (Cohen's d of 2.36), format (6.15), understandability (2.64), as well as user satisfaction (4.94).
Conclusion: The software demonstrated that comprehensive organization of information improves physician's effectiveness and satisfaction in the clinical decision-making process. Further development is needed to map more complex patient pathways, such as the follow-up treatment of prostate cancer.
Competing Interests: NO authors have competing interests.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje